Video

Dr. Hofmeister on the Treatment of Patients with Newly Diagnosed Myeloma

Craig Hofmeister, MD, associate professor, The Ohio State University Comprehensive Cancer Center, discusses the treatment of patients with newly diagnosed multiple myeloma.

Craig Hofmeister, MD, associate professor, The Ohio State University Comprehensive Cancer Center, discusses the treatment of patients with newly diagnosed multiple myeloma.

Patients with multiple myeloma who are fit are usually able to treated with any available agent, says Hofmeister.

The most effective treatment is usually a 3-drug therapy of an immunomodulatory drug, a protostome inhibitor, and dexamethasone, Hofmeister adds.

Related Videos
Thomas Westbrook, MD, assistant professor, Department of Internal Medicine, Rush University
John K. Lee, MD, PhD, associate professor-in-residence, Division of Hematology/Oncology, Department of Medicine; the Institute for Urologic Oncology, Department of Urology, the David Geffen School of Medicine, UCLA Heath
Tae Min Kim, MD, PhD
Whitney Goldsberry, MD
Syed Abbas Ali, MBBS
Farrukh Awan, MD
Jatinder Lamba, PhD, MSc
Alberto Montero, MD
Stephanie L. Graff, MD
Stephanie L. Graff, MD